U.S., Sept. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07844408) titled 'Study of Eye Fatigue From Digital Screens and Its Impact on Visual Performance in People W... Read More
U.S., Sept. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07844889) titled 'Training Diagnostic Specialists to Use Artificial Intelligence Safely: The DISCORD-Dx Stud... Read More
U.S., Sept. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07844629) titled 'Comparing Rectal Artery Embolization and Surgery for Treatment of Bleeding Grade 2 and 3 I... Read More
U.S., Sept. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07843992) titled 'AI-Based Root Canal Length, Curvature, and Morphology Assessment Using CBCT' on Sept. 19. ... Read More
U.S., Sept. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07843719) titled 'Su2ura ESD Closure Pilot Study' on Sept. 22. Brief Summary: This study is a single-center... Read More
U.S., Sept. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07843758) titled 'An External Control Arm Study Comparing Survival Among Metastatic Castration-Resistant Pro... Read More
U.S., Sept. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07844642) titled 'Timing of Success Evaluation After Flapless Treatment of Peri-Implantitis' on Sept. 22. B... Read More
U.S., Sept. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07843849) titled 'Corticosteroid for Diabetic Macular Edema (DME) Study' on Sept. 16. Brief Summary: Our cu... Read More
U.S., Sept. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07843940) titled 'A Study to Test Obrixtamig in Combination With Pumitamig in People With Advanced Small Cel... Read More
U.S., Sept. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07844213) titled 'Early Postoperative Triple Targeted Therapy in Patients With CHD-PAH in the "Grey Zone"' o... Read More